Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Amarin Corporation plc - American Depositary Shares (NQ:AMRN)

12.09 +0.04 (+0.33%)
Delayed Quote Updated: 10:36 AM EST, Nov 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,531
Open 12.20
Bid (Size) 11.91 (200)
Ask (Size) 12.27 (400)
Prev. Close 12.05
Today's Range 12.07 - 12.28
52wk Range 11.25 - 17.31
Shares Outstanding 407,265,944
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Amarin (AMRN) Q3 2026 Earnings Call Transcript ↗
European demand surges 68% as Amarin returns to profitability. 
Via The Motley Fool
Topics Earnings
News headline image
What Amarin (AMRN) Said on Its Q3 Earnings Call ↗
Amarin (NASDAQ:AMRN) reported its first profitable quarter in two years for the third quarter of 2026, as lower operating expenses, positive operating cash flow and growth in international in-market... 
Via MarketBeat
Topics Earnings

Performance

52-Week Range 30.2% below 52-week high
12.09
11.2552W Low 17.3152W High
1 Week 8.3% below 1-week high
11.851W Low 13.181W High

Amarin Corporation plc - American Depositary Shares (AMRN) traded between $11.25 and $17.31 over the past 52 weeks and last traded at $12.09, 30.2% below its 52-week high. Over the past week it ranged between $11.85 and $13.18.

Past 12 Months
-5.1%
N/A
-16.0%
-16.6%
-11.9%
-22.8%
1W -$0.65
1M  
3M -$2.31
6M -$2.41
YTD -$1.63
1Y -$3.57

AMRN was -22.8% over the past year, -16.6% over six months, -11.9% year to date, -5.1% in the last week.

12 Months vs Market
AMRN
-22.8%
DIA
+11.9%
SPY
+12.0%
QQQ
+10.6%
IWM
+15.0%

Over the past 12 months AMRN returned -22.8% versus DIA (Dow) +11.9%, SPY (S&P 500) +12.0%, QQQ (Nasdaq 100) +10.6% and IWM (Russell 2000) +15.0%.

Volume & Liquidity 0.14× 3-mo avg
Today 9,531 3-mo avg 69.3K
1W
98.9K
1M
73.6K
3M
69.3K
6M
71.3K
YTD
75.6K
1Y
78.3K

AMRN most recently traded 9,531 shares against a 3-month average daily volume of 69.3K.

More News

Read More
News headline image
Amarin Reports 2026 Third Quarter Financial Results, Achieves Positive Net Income
From Amarin Corporation plc
Via GlobeNewswire
News headline image
Amarin Provides Update on University of Leeds Sponsored Phase 3 EPA for Metastasis Trial 2 (EMT2) Evaluating VAZKEPA®/VASCEPA® (icosapent ethyl) Capsules on Top of Standard of Care Treatment in Patients Undergoing Liver Resection for Colorectal Cancer
From Amarin Corporation plc
Via GlobeNewswire
Amarin Posts Surprise Q2 Profit on Cost Discipline, Shares Rise Pre-Market (NASDAQ:AMRN) ↗
Via Chartmill
Amarin (NASDAQ:AMRN) Surprises with Revenue Beat but EPS Falls Short Amid Restructuring Costs ↗
Via Chartmill
News headline image
Amarin to Report Third Quarter 2026 Financial Results and Host Conference Call on October 28, 2026
From Amarin Corporation plc
Via GlobeNewswire
News headline image
Amarin Highlights New REDUCE-IT® and Mechanistic Data Presented at European Society of Cardiology (ESC) Congress 2026
From Amarin Corporation plc
Via GlobeNewswire
News headline image
New REDUCE-IT® Legacy Analysis Presented at European Society of Cardiology (ESC) Congress 2026 Suggests Persistent Cardiovascular Benefit Following Icosapent Ethyl Treatment Cessation in Adherent Patients
From Amarin Corporation plc
Via GlobeNewswire
News headline image
New Analyses from REDUCE-IT® and EPA Mechanistic Data to be Presented at the European Society of Cardiology (ESC) Congress 2026
From Amarin Corporation plc
Via GlobeNewswire
News headline image
Amarin (AMRN) Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Amarin Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
Amarin Reports 2026 Second Quarter Financial Results Demonstrating Early Success of Fully Partnered International Commercial Strategy and Continued Leading U.S. Market Presence
From Amarin Corporation plc
Via GlobeNewswire
News headline image
Amarin to Report Second Quarter 2026 Financial Results and Host Conference Call on July 29, 2026
From Amarin Corporation plc
Via GlobeNewswire
News headline image
Amarin Reaffirms the Proven, Guideline-Recommended Role of VASCEPA® (Icosapent Ethyl) in an Evolving Triglyceride Treatment Landscape
From Amarin Corporation plc
Via GlobeNewswire
News headline image
New REDUCE-IT® Analysis Presented at the European Atherosclerosis Society (EAS) Congress 2026 Suggests Risk-Weighted ApoB May Improve Identification of Residual Cardiovascular Risk in Statin-Treated Patients with Hypertriglyceridemia
From Amarin Corporation plc
Via GlobeNewswire
News headline image
Amarin (AMRN) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
News headline image
Amarin Reports 2026 First Quarter Financial Results
From Amarin Corporation plc
Via GlobeNewswire
News headline image
Amarin (AMRN) Q2 2025 Earnings Transcript ↗
Via The Motley Fool
News headline image
Amarin (AMRN) Q3 2025 Earnings Transcript ↗
Via The Motley Fool
Topics World Trade
News headline image
Amarin to Report First Quarter 2026 Financial Results and Host Conference Call on April 29, 2026
From Amarin Corporation plc
Via GlobeNewswire
News headline image
Biohaven Stock Down 70% but One Fund's New $6 Million Bet Signals Turnaround Potential ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Amarin Highlights Guideline Recommended Role of Icosapent Ethyl in Managing Cardiovascular Risk Following Release of Updated 2026 ACC/AHA/Multisociety Dyslipidemia Guideline
From Amarin Corporation plc
Via GlobeNewswire
News headline image
New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual
From Amarin Corporation plc
Via GlobeNewswire
News headline image
Here's Why I Wouldn't Touch Amarin With a 10‑Foot Pole Given Its Patent and Competition Risks ↗
Via The Motley Fool
Topics Intellectual Property

Frequently Asked Questions

Is Amarin Corporation plc - American Depositary Shares publicly traded?
Yes, Amarin Corporation plc - American Depositary Shares is publicly traded.
What exchange does Amarin Corporation plc - American Depositary Shares trade on?
Amarin Corporation plc - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Amarin Corporation plc - American Depositary Shares?
The ticker symbol for Amarin Corporation plc - American Depositary Shares is AMRN on the Nasdaq Stock Market
What is the current price of Amarin Corporation plc - American Depositary Shares?
The current price of Amarin Corporation plc - American Depositary Shares is 12.09
When was Amarin Corporation plc - American Depositary Shares last traded?
The last trade of Amarin Corporation plc - American Depositary Shares was at 11/04/26 10:36 AM ET
What is the market capitalization of Amarin Corporation plc - American Depositary Shares?
The market capitalization of Amarin Corporation plc - American Depositary Shares is 4.92B
How many shares of Amarin Corporation plc - American Depositary Shares are outstanding?
Amarin Corporation plc - American Depositary Shares has 5B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.